文献库搜索 | GeneLibs

Han(B),Lim(HJ),Kim(SJ),Shin(J),Kim(HH),Kim... Anim Cells Syst (Seoul) None

...PIK3CA, and PAK4, using HCT-116, a human colorectal cancer cell line. Using CRISPR-Cas9, we generated individual knockou...

Kocabey(S),Rüegg(C) Small Sci 2026-02-00

...PIK3CA E545K/A and P53 R280K mutations, consistent with Sanger sequencing results and validating our method for liquid b...

Kawachi(K),Tang(X),Kasajima(R),Katayama(K)... Front Oncol None

...PIK3CA were identified in the gILC region, whereas only two nonsynonymous SNVs in SMAD4 and PIK3CA were identified in th...

Blanc-Durand(F),Rouleau(E),Pautier(P),Ngoi... J Gynecol Oncol 2026-01-00

...PIK3CA, CTNNB1, and PTEN mutations. The median overall survival was 42.2, 55.2, and 100.8 months in the LOH-high, interm...

Shaikh(S),Akbar(A),Khalifey(HT),Raziq(T),A... Front Oncol 2026-00-00

...PIK3CA for roughly 10% of curated somatic mutation records pooled across 44 studies (proportions of mutation calls, not ...

Ottaiano(A),Picone(C),Santorsola(M),Berret... Cancers (Basel) 2026-08-28

PIK3CA, which encodes the p110α catalytic subunit of phosphoinositide 3-kinase (PI3K), is one of the most frequently alt...

Brenna(D),Puglisi(M),Epistolio(S),Barizzi(... Int J Mol Sci 2026-09-01

...PIK3CA, and AR amplification. IT-HPV seems to be infrequent in metastatic and locally advanced PCa in Western population...

Othman(NS),Aminuddin(A),Hamid(AA),Abidin(S... Int J Mol Sci 2026-08-24

...PIK3CA as a biologically plausible candidate target for further investigation. This study investigated the functional si...

Gupta(H),Brantley(KD),Grinda(T),Freedman(R... ESMO Open 2026-09-14

...PIK3CA (44%), TP53 (33%), CDH1 (22%) and amplifications in CCND1 (18%). After adjustment, older age was associated with ...

Xu(B),Zhou(X),Xie(Y),Zhou(W) Naunyn Schmiedebergs Arch P... 2026-08-27

...PIK3CA, TNF, RELA, BCL2, and AKT1 as core targets. Molecular docking suggested potential binding interactions, with itra...